Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

PHASE4CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

FPNS

fluticasone propionate nasal spray

DRUG

FFNS

fluticasone furoate nasal spray

DRUG

placebo FFNS

placebo nasal spray matching fluticasone furoate nasal spray

DRUG

placebo FPNS

placebo nasal spray matching fluticasone propionate nasal spray

Trial Locations (28)

11570

GSK Investigational Site, Rockville Centre

14850

GSK Investigational Site, Ithaca

19107

GSK Investigational Site, Philadelphia

19115

GSK Investigational Site, Philadelphia

19426

GSK Investigational Site, Collegeville

20814

GSK Investigational Site, Bethesda

29406

GSK Investigational Site, Charleston

30047

GSK Investigational Site, Lilburn

32308

GSK Investigational Site, Tallahassee

35209

GSK Investigational Site, Birmingham

75230

GSK Investigational Site, Dallas

75231

GSK Investigational Site, Dallas

75246

GSK Investigational Site, Dallas

78130

GSK Investigational Site, New Braunfels

78229

GSK Investigational Site, San Antonio

78731

GSK Investigational Site, Austin

78750

GSK Investigational Site, Austin

79925

GSK Investigational Site, El Paso

85050

GSK Investigational Site, Phoenix

90025

GSK Investigational Site, Los Angeles

90806

GSK Investigational Site, Long Beach

92083

GSK Investigational Site, Vista

92120

GSK Investigational Site, San Diego

92123

GSK Investigational Site, San Diego

94104

GSK Investigational Site, San Francisco

95117

GSK Investigational Site, San Jose

04401

GSK Investigational Site, Bangor

07712

GSK Investigational Site, Ocean City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY